![](/img/cover-not-exists.png)
170 Secukinumab provides sustained improvement in function, quality of life and fatigue over two years in patients who achieved low disease activity related to psoriatic arthritis disease activity score
Coates, Laura C, Kvien, Tore K, Nash, Peter, Gossec, Laure, Strand, Vibeke, Pricop, Luminita, Rasouliyan, Lawrence, Ding, Kevin, Jugl, Steffen, Gaillez, CorineVolume:
57
Language:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/key075.394
Date:
April, 2018
File:
PDF, 71 KB
english, 2018